WINT
USDWindtree Therapeutics Inc. Common Stock
$1.210+0.050 (4.310%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Key Metrics
Market Metrics
Open
$1.160
High
$1.240
Low
$1.150
Volume
0.00M
Company Fundamentals
Market Cap
4.3M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
2.89M
Exchange
NCM
Currency
USD
52-Week Range
Low $1.01Current $1.210High $737.5
Related News
PR Newswire
Evofem Expects Significant Reduction in PHEXXI Manufacturing Cost Through Agreement with Windtree Therapeutics
Evofem Biosciences, Inc. (OTCQB: EVFM) (Evofem or the Company) today announced that it has entered into a License and Supply Agreement (L&S...
View more
GlobeNewswire
Windtree Announces License and Supply Agreement to Become Sourcing Partner for a Small Biotech with an FDA Approved Product
WARRINGTON, Pa., March 20, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. ("Windtree" or the "Company") (NasdaqCM: WINT), a biotechnology company focused on becoming a revenue generating biotech and advancing
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.